<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We retrospectively studied the functional outcomes and recurrence rates of patients 15 years and older in whom cardiogenic <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> was diagnosed at Srinagarind Hospital, Khon Kaen, Thailand, during the period of 1993-2002 </plain></SENT>
<SENT sid="1" pm="."><plain>Ninety patients were included in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Ages ranged from 16-80 years (mean 48.3 years) </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> were <z:e sem="disease" ids="C0035439" disease_type="Disease or Syndrome" abbrv="rhd">rheumatic heart diseases</z:e> (with or without <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>) and nonvulvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>At 3 months and 1 year after <z:hpo ids='HP_0001297'>stroke</z:hpo>, improvement in functional outcome (measured by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RDS</z:e>, motor strength, and GCS) were 74.4% and 55.6%, mortality rates of 13.3% and 16.7%; and recurrence rates of 8.9% and 16.7%, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>A GCS &lt; 9 or motor power &lt; or = 1 or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RDS</z:e> &gt; or = 4 upon presentation were poor prognostic factors </plain></SENT>
</text></document>